Scientific, Photographic and Control Equipment

Semiconductors and Other Electronic Components

Wholesalers: Electronics and Office Equipment

The Morning Consult Brand Index is an indicator of brand strength among consumers. Each Fortune 500 company receives a score based on a ratio of favorable to unfavorable impressions among U.S. adults and its overall favorability. This ensures that a score takes into account how well-liked a company is among people who have an opinion of it without penalizing companies that are not consumer-facing.

Morning Consult polls thousands of adults across the country each week. The surveys are conducted online using large, established online survey vendors. The data is weighted to approximate a nationally representative sample based on age, race/ethnicity, gender, educational attainment, region, annual household income, home ownership status and marital status.

Americas largest pharmaceutical distributor slips one spot on the 500 this year, but the continued strength of its distribution businessserving as the middleman between manufacturers and pharmacieslifted revenues 3% in 2017. The acquisition of Rexall Health powered some of that growth as did trends like the nations climbing drug prices and rising drug utilization rates.McKessonalso moved ahead with its plan to divest its technology businesses in deals with Change Healthcare and Allscripts. The company, along with the countrys other large drug distributors, remains a target of litigation over its alleged role in the nations opioid epidemic.

Looking for leads, investment insights, or competitive intelligence?

Figures are for fiscal year ended March 31, 2017.

Total Return to Investors (5 year, annualized)

Total Return to Investors (10 year, annualized)

McKessons Longtime CEO Is Stepping Down. His Last Years Were Rocked by the Opioid Crisis

John Hammergren is retiring after nearly two decades on the job.

The decision to sue is seen as an acknowledgment opioid makers wont get serious about settling until the cases go to trial.

The presidents drug price proposals didnt shake big pharma and other health care companies.

Attorney General Jeff Sessions announced a statement of intent to prop up suits against opioid makers and distributors.

Sparking a selloff in the shares of a host of health care-related companies.

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by